New developments in the chemotherapy of leishmaniasis

REFERENCES

• Alving, C. R., Steck, E. A., Hansen, W. L., Loizeau, P. S., Chapman Jr, W. L. & Watts, V. B. (1978). Improved therapy of experimental leishmaniasis by use of a liposome-encapsulated antimonial drug. Life Sciences, 22, 1021–1025.
   PubMed Web of Science ®Google Scholar
• Badaro, R., Falcoff, E., Badaro, F. S., Carvalho, E. M., Pedral-Sampaio, D., Barral, A., Carvalho, J. S., Barral-Netto, M., Brandely, M., Silva, S., Bina, J. C., Tekeira, R., Falcoff, R., Rocha, H., Ho, J. L. & Johnson Jr, W. D. (1990). Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. New England Journal of Medicine, 322, 16–21.
   PubMed Web of Science ®Google Scholar
• Badaro, R., Nascimento, C., Carvalho, J. S., Badaro, F., Russo, D., Ho, J. L., Re, S. G., Johnson, W. D. & Jones, T. C. (1994). Recombinant human granulocyte-macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasis. Journal of Infectious Diseases, 170, 413–418.
   PubMed Web of Science ®Google Scholar
• Black, C. D. V., Watson, G. J. & Ward, R. J. (1977). The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 71, 550–552.
   PubMed Web of Science ®Google Scholar
• Bryceson, A. D. M. (1987). Therapy in man. In The Leishmaniasis in Biology and Medicine, Vol. 2, eds Peters, W. & Killick-Kendrick, R. pp. 847–907. London: Academic Press.
   Google Scholar
• Bryceson, A. D. M., Murphy, A. & Moody, A. H. (1994). Treatment of ‘Old World’ cutaneous leishmaniasis with aminosidine ointment: results of an open study in London. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88, 226–228.
   PubMed Web of Science ®Google Scholar
• Chulay, J. D., Bhatt, S. M., Muigai, R., Ho, M., Gachihi, J., Were, J. B. O., Chunge, C. & Bryceson, A. D. M. (1983). A comparison of three dosage regimens of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya. Journal of Infectious Diseases, 148, 148–155.
   PubMed Web of Science ®Google Scholar
• Chunge, C. N., Owate, J., Pamba, H. O. & Donno, L. (1990). Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 221–225.
   PubMed Web of Science ®Google Scholar
• Davidson, R. N. & Croft, S. L, (1993). Recent advances in the treatment of visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 130–131, 141.
   PubMed Web of Science ®Google Scholar
• Davidson, R. N., di, Martino, L., Gradoni, L., Giacchino, R., Russo, R., Gaeta, G. B., Pempinello, R., Scott, S., Raimondi, F., Cascio, A., Prestileo, T., Caldeira, L., Wilkinson, R. J. & Bryceson, A. D. M. (1994). Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial. Quarterly Journal of Medicine, 87, 75–81.
   PubMedGoogle Scholar
• Dietze, R., Fagundes, S. M. S., Brito, E. F., Milan, E. P., Fietosa, T. F., Suassuna, F. A. B., Fonschiffrey, G., Ksionski, G. & Dember, J. (1995). Treatment of kala-azar in Brazil with Amphocil® (amphotericin B cholesterol dispersion) for 5 days. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 309–311.
   PubMed Web of Science ®Google Scholar
• Dietze, R., Milan, E. P., Berman, J. D., Grogl, M., Falqueto, A., Fietosa, T. F., Luz, K. G., Suassuna, F. A. B., Marinho, L. A. C. & Ksionski, G. (1993). Treatment of Brazilian kala-azar with a short course of Amphocil® (amphotericin B cholesterol dispersion). Clinical Infectious Diseases, 17, 981–986.
   PubMed Web of Science ®Google Scholar
• El-On, J., Halevy, S., Grunwald, M. H. & Weinrauch, L. (1992). Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study. Journal of the American Academy of Dermatology, 27, 227–231.
   PubMed Web of Science ®Google Scholar
• Franke, E. D., Llanos-Cuentas, A., Echevarria, J., Cruz, M. E., Campos, P., Tovar, A. A., Lucas, C. M. & Berman, J. D. (1994). Efficacy of 28-day and 40-day regimens of sodium stibogluconate (Pentostam) in the treatment of mucosal leishmaniasis. American Journal of Tropical Medicine and Hygiene, 51, 77–82.
   PubMed Web of Science ®Google Scholar
• Goad, L. J., Holz Jr, G. G. & Beach, D. H. (1984). Sterols of Leishmania species, implications for biosynthesis. Molecular and Biochemical Parasitology, 10, 161–170.
   PubMed Web of Science ®Google Scholar
• Goad, L. J., Holz Jr, G. G. & Beach, D. H. (1985). Sterols of ketoconazole-inhibited Leishmania mexicana mexicana promastigotes. Molecular and Biochemical Parasitology, 15, 257–279.
   PubMed Web of Science ®Google Scholar
• Goodwin, L. G. (1995). Pentostam® (sodium stibogluconate); a 50-year personal reminiscence. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 339–341.
   PubMed Web of Science ®Google Scholar
• Gradoni, L., Bryceson, A. & Desjeux, P. (1995). Treatment of Mediterranean visceral leishmaniasis. Bulletin of the World Health Organization, 73, 191–197.
   PubMed Web of Science ®Google Scholar
• Haughan, P. A., Chance, M. L. & Goad, L. J. (1992). Synergism in vitro of lovastatin and miconazole as anti-leishmanial agents. Biochemical Pharmacology, 434, 2199–2206.
   Web of Science ®Google Scholar
• Haughan, P. A., Chance, M. L. & Goad, L. J. (1995). Effects of an azasterol inhibitor of sterol 24-transmethylation on sterol biosynthesis and growth of Leishmania donovani promastigotes. Biochemistry Journal, 308, 31–38.
   PubMed Web of Science ®Google Scholar
• Heath, S., Chance, M. L. & New, R. R. C. (1984). Quantitative and ultrastructural studies on the uptake of drug loaded liposomes by mononuclear phagocytes infected with Leishmania donovani. Molecular and Biochemical Parasitology, 12, 49–60.
   PubMed Web of Science ®Google Scholar
• Hepburn, N. C., Tidman, M. J. & Hunter, J. A. A. (1994). Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88, 700–703.
   PubMed Web of Science ®Google Scholar
• Krause, G. & Kroeger, A. (1994). Topical treatment of American cutaneous leishmaniasis with paromomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88, 92–94.
   PubMed Web of Science ®Google Scholar
• Larbi, E. B., Al-Khawajah, A., Al-Gindan, Y., Jain, S., Abahusain, A. & Al-Zayer, A. (1995). A randomized, double-blind, clinical trial of topical clotrimazole versus miconazole for treatment of cutaneous leishmaniasis in the eastern province of Saudi Arabia. American Journal of Tropical Medicine and Hygiene, 52, 166–168.
   PubMed Web of Science ®Google Scholar
• Mishra, M., Biswas, U. K., Jha, A. M. & Khan, A. B. (1994). Amphotericin versus sodium stibogluconate in first-fine treatment of Indian kala-azar. Lancet, ii, 1599–1600.
   Google Scholar
• Navin, T. R., Arana, B. A., Arana, F. E., Berman, J. D. & Chajon, J. F. (1992). Placebo controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. Journal of Infectious Diseases, 165, 528–534.
   PubMed Web of Science ®Google Scholar
• Neal, R. A., Murphy, A. G., Olliaro, P. & Croft, S. L. (1994). Aminosidine ointments for the treatment of experimental cutaneous leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88, 223–225.
   PubMed Web of Science ®Google Scholar
• New, R. R. C., Chance, M. L. & Heath, S. (1981a). Antileishmanial activity of amphotericin and other antifungal agents entrapped in liposomes. Journal of Antimicrobial Chemotherapy, 8, 371–381.
   PubMed Web of Science ®Google Scholar
• New, R. R. C., Chance, M. L. & Heath, S. (1981a). The treatment of experimental cutaneous leishmaniasis with liposome-entrapped Pentostam. Parasitology, 83, 519–527.
   Web of Science ®Google Scholar
• New, R. R. C, Chance, M. L., Thomas, S. C. & Peters, W. (1978). Antileishmanial activity of antimonials entrapped in liposomes. Nature, 272, 55–56.
   PubMed Web of Science ®Google Scholar
• Olliaro, P. L. & Bryceson, A. D. M. (1993). Practical progress and new drugs for changing patterns of leishmaniasis. Parasitology Today, 9, 323–328.
   PubMedGoogle Scholar
• Rees, P. H., Keating, M. I., Kager, P. A. & Hockmeyer, W. T. (1980). Renal clearance of pentavalent antimony (sodium stibogluconate). Lancet, ii, 226–229.
   Google Scholar
• Seaman, J., Pryce, D., Sondorp, H. E., Moody, A., Bryceson, A. D. & Davidson, R. N. (1993). Epidemic visceral leishmaniasis in Sudan: a randomized trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone. Journal of Infectious Disease, 168, 715–720.
   PubMed Web of Science ®Google Scholar
• Soto, J., Grogl, M., Berman, J. & Olliaro, P. (1994). Limited efficacy of injectable aminosidine as single-agent therapy for Colombian cutaneous leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88, 695–698.
   PubMed Web of Science ®Google Scholar
• Sundar, S., Rosenkaimer, F. & Murray, H. W. (1994). Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-γ. Journal of Infectious Diseases, 170, 659–662.
   PubMed Web of Science ®Google Scholar
• Teklemariam, S., Hiwot, A. G., Frommel, D., Mnco, T. L., Ganlov, G. & Bryceson, A. (1994). Aminosidine and its combination with sodium stibogluconate in the treatment of diffuse cutaneous leishmaniasis caused by Leishmania aethiopica. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88, 334–339.
   PubMed Web of Science ®Google Scholar
• Thakur, C. P. (1994). Comparison of glucose versus fat emulsion in the preparation of amphotericin B for use in kala-azar. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88, 698–699.
   PubMed Web of Science ®Google Scholar
• Thakur, C. P., Bhowmick, S., Dolff, L. & Olliaro, P. (1995). Aminosidine plus sodium stibogluconate for the treatment of Indian kala-azar; a randomized dose-finding clinical trial. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 219–223.
   PubMed Web of Science ®Google Scholar
• Torre-Cisneros, J., Prada, J. L., Villanueva, J. L., Ververde, F. & Sanchez-Guijo, P. (1994). Successful treatment of antimony-resistant cutaneous leishmaniasis with liposomal amphotericin B. Clinical Infectious Diseases, 178, 1024–1025.
   Google Scholar